Polypharmacy prevalence and associated factors in patients with systemic lupus erythematosus: A single-centre, cross-sectional study.

Hirofumi Miyake,Ryuichi Minoda Sada,Hiroyuki Akebo,Yukio Tsugihashi,Kazuhiro Hatta

Modern rheumatology（2022）

引用 2|浏览2

暂无评分

摘要

Polypharmacy and excessive polypharmacy in patients with systemic lupus erythematosus are related to medical aspects such as disease severity and comorbidities in addition to social aspects such as hospital visitation patterns and economic status.

查看译文

关键词

Charlson comorbidity index,excessive polypharmacy,polypharmacy,systemic lupus erythematosus

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要